Semaglutide: A Promising Ally Against Alzheimer’s?
In a groundbreaking study, researchers at Case Western Reserve School of Medicine have identified a potential new benefit of semaglutide, a widely used diabetes and weight-loss drug. According to their findings, semaglutide may significantly reduce the risk of Alzheimer’s disease in individuals with type 2 diabetes (T2D), outperforming seven other anti-diabetic medications.
Alzheimer’s disease, a devastating brain disorder that erodes memory and cognitive abilities, affects nearly 7 million Americans aged 65 and older, as reported by the Alzheimer’s Association. Alarmingly, it claims more lives annually than breast and prostate cancer combined.
Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the study suggests that T2D patients taking semaglutide had a markedly lower risk of developing Alzheimer’s disease. This trend was consistent across various subgroups, regardless of obesity status, gender, or age.
Semaglutide, a glucagon-like peptide receptor (GLP-1R) agonist, is the active ingredient in popular medications like Wegovy and Ozempic. It works by reducing hunger and regulating blood sugar levels in T2D patients.
Under the leadership of Rong Xu, a professor of biomedical informatics, the research team analyzed three years of electronic health records from nearly one million U.S. patients with T2D. Their statistical approach, which mimicked a randomized clinical trial, revealed that patients prescribed semaglutide had a significantly lower risk of Alzheimer’s compared to those on other anti-diabetic medications.
According to the CDC, Alzheimer’s disease results in approximately 120,000 deaths annually, ranking as the seventh-leading cause of death in the United States.
“This new study provides real-world evidence for semaglutide’s potential impact on Alzheimer’s disease,” Xu stated. “While preclinical research has hinted at its protective effects against neurodegeneration and neuroinflammation, our findings suggest the need for further exploration through randomized clinical trials.”
Despite these promising results, the study’s limitations prevent researchers from drawing definitive causal conclusions. Xu emphasized the importance of continued research into semaglutide’s potential as a treatment for this debilitating condition, encouraging further investigation into alternative drugs.
For more information, please contact Patty Zamora at [email protected].
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
The Phoenix housing market continues to outperform the rest of the country, posting stronger sales, rising equity, and an influx of qualified buyers. With closed sales, pending sales, new listings, and median prices all trending upward, the Valley is outpacing national growth by a wide margin. City‑level data shows impressive strength across Scottsdale, Goodyear, Gilbert, Phoenix, and more—making 2025 a powerful year for agents, investors, and professionals watching the Arizona market.
With the 2026 FIFA World Cup and America’s 250th birthday celebrations on the horizon, the U.S. job market is gearing up for a surge across multiple industries. Seasonal, flexible, and part‑time roles are expected to rise—especially for workers 50+ who have struggled in a cooling labor market. From accounting and HR leadership to event staffing and delivery driving, major cities are preparing for increased hiring tied to tourism, infrastructure, and yearlong national celebrations. Many of these fast‑growing roles connect directly to licensing and certification pathways, giving professionals new chances to pivot or upskill through programs offered by Cameron Academy.
Florida is rolling out a new wave of laws on January 1, 2026 that will impact professionals in real estate, insurance, healthcare, education, and other regulated industries. From new insurance rules and healthcare billing requirements to condo association deadlines and statewide databases, these updates reshape compliance expectations across the state. Whether you work in property, finance, or public‑facing services, understanding these changes is essential for staying aligned with Florida’s evolving regulations.
Nearly every commercial real estate professional is expecting a stronger year ahead, with 97% predicting increased or stable activity in 2026, according to Avison Young’s latest outlook. Confidence has surged dramatically since mid‑2025 as strong sales, anticipated rate cuts, and improving fundamentals across key sectors signal that CRE recovery and growth may finally be taking hold.
Dallas‑Fort Worth is finishing 2025 as the nation’s top real estate and business powerhouse, fueled by corporate relocations, a dominant industrial sector, infrastructure megaprojects, and a rapidly evolving workforce landscape. From data center expansion to the launch of the DART Silver Line, the region continues to outpace national trends—while also confronting a growing demand for skilled professionals and licensed talent across construction, real estate, and technical fields.
FEMA and the NJDEP have released revised preliminary flood maps for Morris County, reshaping how homeowners, real estate agents, insurers, and mortgage professionals assess flood risk. The updated FIRMs may shift properties into or out of higher‑risk zones, affecting insurance requirements, closing processes, and long‑term property values. With public review and appeals ahead, industry professionals are urged to study the changes now and prepare clients for potential impacts.
